Jean-Martin CharcotCharcot's primary focus was neurology. He named and was the first to describe multiple sclerosis. Summarizing previous reports and adding his own clinical and pathological observations, Charcot called the disease sclerose en plaques. The three signs of Multiple sclerosis now known as Charcot's triad 1 are nystagmus, intention tremor, and telegraphic speech, though these are not unique to MS. Charcot also observed cognition changes, describing his patients as having a "marked enfeeblement of the memory" and "conceptions that formed slowly". He was also the first to describe a disorder known as Charcot joint or Charcot arthropathy, a degeneration of joint surfaces resulting from loss of proprioception. He researched the functions of different parts of the brain and the role of arteries in cerebral hemorrhage.
Charcot was among the first to describe Charcot-Marie-Tooth disease (CMT). The announcement was made simultaneously with Pierre Marie of France (his resident) and Howard Henry Tooth of England. The disease is also sometimes called peroneal muscular atrophy.
Charcot's studies between 1868 and 1881 were a landmark in the understanding of Parkinson's disease. Among other advances he made the distinction between rigidity, weakness and bradykinesia. He also led the disease formerly named paralysis agitans (shaking palsy) to be renamed after James Parkinson. Charcot received the first European professional chair of clinical diseases for the nervous system in 1882.
for more info go to wikipedia